Teva: Generic drug giant stumbles into NJ with $40M tax break from you
DBRS Morningstar: Italian Banks Higher Net Interest Income To Offset Risks From Weaker Economic Prospects
Morningstar Advisor - April/May 2010 - 63
What Litigation Risk Means for Big Pharma and Biotech Valuations | Morningstar
Digging Into Berkshire Hathaway's Portfolio | Morningstar
Teva Pharmaceutical Industries Company Profile: Stock Performance & Earnings | PitchBook
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Investing Insights | Morningstar
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Teva: Generic drug giant stumbles into NJ with $40M tax break from you
Covidien's Mallinckrodt Spin-Off Faces Challenging Environment | Morningstar
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Teva Is The Drug Industry's Comeback Story (NYSE:TEVA) | Seeking Alpha
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
Teva Sued by U.S. Over Alleged Copaxone Kickbacks - TheStreet
Teva Pharmaceutical Industries Is Turning A Corner (NYSE:TEVA) | Seeking Alpha
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Teva Pharmaceutical Industries Is Turning A Corner (NYSE:TEVA) | Seeking Alpha
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
Teva Pharmaceutical Industries Is Turning A Corner (NYSE:TEVA) | Seeking Alpha
Morningstar 2011/2012 - 38
3 Warren Buffett Stocks on Sale | Morningstar
Markets Brief: What to Watch for in Q1 Earnings, CPI | Morningstar
Teva Has Turned the Corner - GuruFocus.com
Morningstar Funds Trust - Morningstar Multi-Sector Bond Fund - Portfolio Holdings, AUM (13F, 13G)
Teva Pharmaceutical Industries Is Turning A Corner (NYSE:TEVA) | Seeking Alpha
